Research & Development

256彩票博彩256彩票网址导航258nba篮球彩票瑞信:青啤升目标价至65港元 维持跑赢大市评级


  “唔,快說。”   然後童杰奔來︰“爹,我幫你!”他一拳打在棗樹樹干上,小鳥害怕地飛走了。256彩票博彩   “大人你本來就身染寒癥,又這麼不小心掉到了水潭里,那百年古潭的潭水比雪水還要冷十倍呀,這次恢復起來起碼需要十天半月了。”邢郎中道。256彩票网址导航   ∥繼承始末∥ 258nba篮球彩票   “怎麼樣,鄭警官?有發現嗎?”那管理員好奇地問。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo